ArticleFrontiers in pharmacology2025
Global trends and collaborations in bortezomib-induced neurotoxicity research: a bibliometric analysis (2002-2024).
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Hematological malignancies pose significant health challenges, with bortezomib emerging as a key therapeutic agent. However, its use is complicated by neurotoxicity, a side effect that urgently requires mitigation strategies. This study aims to provide a comprehensive bibliometric analysis to map the intellectual structure, historical trends, and emerging research fronts in the field of bortezomib-induced neurotoxicity. Methods: We conducted a systematic search in the Web of Science Core Collection, capturing literature from 2002 to 2024. Articles written in English were selected for analysis. Bibliometric analysis was performed using VOSviewer, CiteSpace, and R 4.3.3 to visualize collaborations, keyword co-occurrences, and bibliographic coupling. Results: The overview of this study reveals a rich tapestry of academic engagement encompassing 745 publications. The USA and China were the most productive countries, with Harvard University and the Dana-Farber Cancer Institute leading in institutional contributions. The New England Journal of Medicine stood out as the most influential journal. Prominent authors like Richardson Paul G. showcased the highest impact, with central research themes focusing on therapeutic approaches and peripheral neuropathy. Conclusion: This bibliometric analysis provides a detailed overview of the research landscape in bortezomib-induced neurotoxicity, identifying the USA and China as leading contributors and highlighting the central focus on therapeutic strategies and peripheral neuropathy management. These findings emphasize the need for global collaboration to develop effective mitigation strategies for neurotoxicity and improve patient outcomes. Insights from this study can guide future research efforts and inform clinical practices in managing bortezomib-related side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.